INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 48s ago
House PTR8s ago
SEC 13F6h ago
Robinhood Chain6h ago

Results

26,451 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
32
AE
Abraham EuanChief Hardware & Mftg Offcr
SERVServe Robotics Inc. /DE/
Open-market sale
SELL$14K
1,375 sh
Feb 11, 2026Feb 12, 2026
Page 505 of 662
← PrevNext →
traded Feb 11, 2026
+1d
SEC Form 4

Evidence

32
RK
Rasmussen KrisChief Technology Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$5.14M
205.4K sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC Form 4

Evidence

31
HJ
Hill Stephen J.Chief Operating Officer
LYELLyell Immunopharma, Inc.
Open-market sale
SELL$29K
1,236 sh
Feb 11, 2026Feb 12, 2026
traded Feb 11, 2026
+1dSEC Form 4

Evidence

31
LK
Lee Gary K.Chief Scientific Officer
LYELLyell Immunopharma, Inc.
Open-market sale
SELL$39K
1,671 sh
Feb 11, 2026Feb 12, 2026
traded Feb 11, 2026
+1dSEC Form 4

Evidence

30
GL
Goldstein Robert L.Chief Operating Officer
BLKBlackRock, Inc.
Open-market sale
SELL$987K
911 sh
Feb 11, 2026Feb 12, 2026
traded Feb 11, 2026
+1dSEC Form 4

Evidence

30
AS
Ahamad SamsheerSee Remarks
SITMSITIME Corp
Open-market sale
SELL$4.02M
9,100 sh
Feb 11, 2026Feb 12, 2026
traded Feb 11, 2026
+1dSEC Form 4

Evidence

30
GL
Goldstein Robert L.Chief Operating Officer
BLKBlackRock, Inc.
Open-market sale
SELL$519K
478 sh
Feb 11, 2026Feb 12, 2026
traded Feb 11, 2026
+1dSEC Form 4

Evidence

29
RB
Read BrianChief Financial Officer
SERVServe Robotics Inc. /DE/
Open-market sale
SELL$1,881
185 sh
Feb 11, 2026Feb 12, 2026
traded Feb 11, 2026
+1dSEC Form 4

Evidence

29
ZF
Zalenko Neal F.Director
GRFEAGLE CAPITAL GROWTH FUND, INC.
Open-market purchase
BUY$16K
1,400 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC Form 4

Evidence

29
PT
Parang TourajDirector, President & COO
SERVServe Robotics Inc. /DE/
Open-market sale
SELL$36K
3,558 sh
Feb 11, 2026Feb 12, 2026
traded Feb 11, 2026
+1dSEC Form 4

Evidence

28
FE
Freeland James E.VP, Chief Information Officer
DGIIDIGI INTERNATIONAL INC
Open-market sale
SELL$62K
1,355 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC Form 4

Evidence

28
Kelly MorrisonDSelf
AMIAdvanced Machine Intelligence Labs
Purchase
BUY$15K – $50KJan 29, 2026Feb 12, 2026
traded Jan 29, 2026
+14dHouse PTR

Evidence

28
Mike KellyRSpouse
NDN TX Tollway Auth Revenue Second Tie Rev 5% due 1/1/34
Purchase
BUY$15K – $50KJan 20, 2026Feb 12, 2026
traded Jan 20, 2026
+23dHouse PTR

Evidence

28
Byron DonaldsRSpouse
BBBitcoin (CRYPTO:BTC)
Purchase
BUY$1,001 – $15KJan 8, 2026Feb 12, 2026
traded Jan 8, 2026
+35dHouse PTR

Evidence

26
MB
Mulligan BrendanGeneral Counsel and Secretary
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$131K
5,227 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC Form 4

Evidence

25
ZF
Zalenko Neal F.Director
GRFEAGLE CAPITAL GROWTH FUND, INC.
Open-market purchase
BUY$11K
1,000 sh
Feb 12, 2026Feb 12, 2026
traded Feb 12, 2026
+0dSEC Form 4

Evidence

24
ML
Magic Internacional Argentina FC S.L. LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$117K
12.2K sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC Form 4

Evidence

24
Mike KellyRSpouse
FDFlorida St Hsg Fin Corp Revenue Social Bon Rev Call 07/01/30 3% due 7/1/52
Partial sale
SELL$1,001 – $15KJan 2, 2026Feb 12, 2026
traded Jan 2, 2026
+41dHouse PTR

Evidence

24
Byron DonaldsRSelf
TTDTrade Desk, Inc.
Sale
SELL$1,001 – $15KJan 8, 2026Feb 12, 2026
traded Jan 8, 2026
+35dHouse PTR

Evidence

24
Byron DonaldsRSelf
HWMHowmet Aerospace Inc.
Partial sale
SELL$1,001 – $15KJan 8, 2026Feb 12, 2026
traded Jan 8, 2026
+35dHouse PTR

Evidence

24
Byron DonaldsRSelf
PHParker-Hannifin Corp
Partial sale
SELL$1,001 – $15KJan 8, 2026Feb 12, 2026
traded Jan 8, 2026
+35dHouse PTR

Evidence

24
Byron DonaldsRSpouse
TTDTrade Desk, Inc.
Sale
SELL$1,001 – $15KJan 8, 2026Feb 12, 2026
traded Jan 8, 2026
+35dHouse PTR

Evidence

17
MC
Malenka Robert C.Director
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$120K
6,622 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC Form 4

Evidence

17
ML
Magic Internacional Argentina FC S.L. LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$19K
2,080 sh
Feb 11, 2026Feb 12, 2026
traded Feb 11, 2026
+1dSEC Form 4

Evidence

14
MC
Malenka Robert C.Director
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$4,338
241 sh
Feb 11, 2026Feb 12, 2026
traded Feb 11, 2026
+1dSEC Form 4

Evidence

7
WT
Weingarten TomerDirector, President, CEO
SSentinelOne, Inc.
Open-market sale · 10b5-1 plan
SELL$532K
39.5K sh
Feb 11, 2026Feb 12, 2026
traded Feb 11, 2026
+1dSEC Form 4

Evidence

6
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$86K
8,357 sh
Feb 11, 2026Feb 12, 2026
traded Feb 11, 2026
+1dSEC Form 4

Evidence

6
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$113K
10.8K sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC Form 4

Evidence

5
CG
Clark Joseph GatesSVP and Pres, Optimized LED
PENGPenguin Solutions, Inc.
Open-market sale · 10b5-1 plan
SELL$26K
1,346 sh
Feb 10, 2026Feb 12, 2026
traded Feb 10, 2026
+2dSEC Form 4

Evidence

57
GM
Glibert Christian Michael10% Owner
FEEDENvue Medical, Inc.
Open-market purchase
BUY$641K
240.0K sh
Jan 14, 2026Feb 11, 2026
traded Jan 14, 2026
+28dSEC Form 4

Evidence

54
GS
Golten Alex SCHIEF RISK OFFICER
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$288K
307 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

54
GS
Golten Alex SCHIEF RISK OFFICER
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$511K
545 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

50
KA
Khan Bilal ArshadDirector
SGPSpyGlass Pharma, Inc.
Open-market purchase
BUY$1.84M
115.0K sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

49
CP
Coleman Denis P.Chief Financial Officer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$2.69M
2,844 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

47
GS
Golten Alex SCHIEF RISK OFFICER
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$225K
240 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

47
KA
Khan Bilal ArshadDirector
SGPSpyGlass Pharma, Inc.
Open-market purchase
BUY$320K
20.0K sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

46
GS
Golten Alex SCHIEF RISK OFFICER
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$336K
360 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

46
GS
Golten Alex SCHIEF RISK OFFICER
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$784K
840 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence

45
SW
Smith David WVP, Sustainability
CSLCARLISLE COMPANIES INC
Open-market sale
SELL$422K
1,020 sh
Feb 10, 2026Feb 11, 2026
traded Feb 10, 2026
+1dSEC Form 4

Evidence

45
CP
Coleman Denis P.Chief Financial Officer
GSGOLDMAN SACHS GROUP INC
Open-market sale
SELL$1.01M
1,076 sh
Feb 9, 2026Feb 11, 2026
traded Feb 9, 2026
+2dSEC Form 4

Evidence